Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/70245

TitleModulating inflammation through the neutralization of Interleukin-6 and tumor necrosis factor-α by biofunctionalized nanoparticles
Author(s)Lima, Ana Cláudia Fernandes
Amorim, Diana Alexandra Silva
Laranjeira, Inês
Almeida, Armando
Reis, R. L.
Ferreira, Helena Susana Costa Machado
Pinto-Ribeiro, Filipa
Neves, N. M.
KeywordsAntibodies immobilization
Inflammation
Interleukin-6 and tumor necrosis factor-α neutralization
Polymeric nanoparticles
Issue dateMar-2021
PublisherElsevier
JournalJournal of Controlled Release
CitationLima Ana C., Amorim D., Laranjeira I., Almeida A., Reis R. L., Ferreira H., Pinto-Ribeiro F., Neves N. M. Modulating inflammation through the neutralization of Interleukin-6 and tumor necrosis factor-α by biofunctionalized nanoparticles , Journal Of Controlled Release, Vol. 331, pp. 491–502, doi:10.1016/j.jconrel.2021.02.001, 2021
Abstract(s)Biological agents that neutralize the activity of pro-inflammatory cytokines are revolutionizing the treatment of inflammatory conditions. However, the antibodies (Abs) short half-life and off-target distribution critically limit their efficacy and safety. Therefore, this work proposes the immobilization of anti-TNF-α and anti-IL-6 Abs at the surface of polymeric nanoparticles (NPs) in order to extend and increase the Abs therapeutic efficacy, owing to the protection from degradation that the NPs provide, and to avoid off-target side effects through local administration. In an in vitro model of inflammation, biofunctionalized NPs were able to reduce the harmful effects on human chondrocytes provided by inflammatory macrophages, being demonstrated the additive effects of the dual neutralization. Significantly, biofunctionalized NPs ameliorated inflammation more efficiently than soluble Abs in an in vivo experimental model of inflammation, exhibiting a safe profile, a prolonged action, and a stronger efficacy. Hence, as this strategy is able to increase the therapeutic efficacy of the currently available treatments, it is a promising potential therapeutic option for inflammatory conditions.
TypeArticle
URIhttp://hdl.handle.net/1822/70245
DOI10.1016/j.jconrel.2021.02.001
ISSN0168-3659
Publisher versionhttps://www.sciencedirect.com/science/article/pii/S0168365921000481?via%3Dihub
Peer-Reviewedyes
AccessRestricted access (UMinho)
Appears in Collections:3B’s - Artigos em revistas/Papers in scientific journals

Files in This Item:
File Description SizeFormat 
20493-1-s2.0-S0168365921000481-main.pdf
  Restricted access
10,27 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID